Legal & General Group’s Epizyme, Inc EPZM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-69,205
Closed -$102K 3532
2022
Q2
$102K Buy
69,205
+15,296
+28% +$11.2K ﹤0.01% 2853
2022
Q1
$62K Sell
53,909
-8,858
-14% -$14.4K ﹤0.01% 2963
2021
Q4
$157K Hold
62,767
﹤0.01% 2799
2021
Q3
$321K Buy
62,767
+14,081
+29% +$85.5K ﹤0.01% 2547
2021
Q2
$404K Buy
48,686
+726
+2% +$6.12K ﹤0.01% 2377
2021
Q1
$418K Sell
47,960
-715
-1% -$7.4K ﹤0.01% 2328
2020
Q4
$528K Sell
48,675
-142
-0.3% -$1.75K ﹤0.01% 2251
2020
Q3
$582K Sell
48,817
-3,821
-7% -$51.2K ﹤0.01% 2174
2020
Q2
$846K Buy
52,638
+8,714
+20% +$152K ﹤0.01% 2028
2020
Q1
$681K Buy
43,924
+23,604
+116% +$507K ﹤0.01% 1976
2019
Q4
$500K Buy
20,320
+4,086
+25% +$60.7K ﹤0.01% 2217
2019
Q3
$168K Buy
16,234
+1,303
+9% +$16.4K ﹤0.01% 2386
2019
Q2
$188K Buy
14,931
+3,270
+28% +$42.1K ﹤0.01% 2366
2019
Q1
$144K Buy
11,661
+1,601
+16% +$17.9K ﹤0.01% 2398
2018
Q4
$62K Buy
10,060
+1,455
+17% +$11.1K ﹤0.01% 2616
2018
Q3
$92K Hold
8,605
﹤0.01% 2537
2018
Q2
$117K Sell
8,605
-878
-9% -$13.7K ﹤0.01% 2452
2018
Q1
$168K Sell
9,483
-2,019
-18% -$34.1K ﹤0.01% 2339
2017
Q4
$146K Buy
11,502
+363
+3% +$5.28K ﹤0.01% 2430
2017
Q3
$208K Buy
11,139
+1,455
+15% +$22.2K ﹤0.01% 2333
2017
Q2
$147K Hold
9,684
﹤0.01% 2416
2017
Q1
$165K Buy
9,684
+795
+9% +$10.6K ﹤0.01% 2320
2016
Q4
$108K Buy
8,889
+1,414
+19% +$14.8K ﹤0.01% 2518
2016
Q3
$71K Hold
7,475
﹤0.01% 2365
2016
Q2
$78K Hold
7,475
﹤0.01% 2240
2016
Q1
$95K Buy
7,475
+2,421
+48% +$24.5K ﹤0.01% 2081
2015
Q4
$84K Hold
5,054
﹤0.01% 2183
2015
Q3
$63K Hold
5,054
﹤0.01% 2323
2015
Q2
$107K Buy
5,054
+2,516
+99% +$48.4K ﹤0.01% 2057
2015
Q1
$48K Hold
2,538
﹤0.01% 2510
2014
Q4
$47K Hold
2,538
﹤0.01% 2465
2014
Q3
$69K Buy
+2,538
New +$78.9K ﹤0.01% 2178

Other funds holding EPZM